290 related articles for article (PubMed ID: 31671668)
1. PFKFB3 Inhibition Attenuates Oxaliplatin-Induced Autophagy and Enhances Its Cytotoxicity in Colon Cancer Cells.
Yan S; Zhou N; Zhang D; Zhang K; Zheng W; Bao Y; Yang W
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671668
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.
Clem B; Telang S; Clem A; Yalcin A; Meier J; Simmons A; Rasku MA; Arumugam S; Dean WL; Eaton J; Lane A; Trent JO; Chesney J
Mol Cancer Ther; 2008 Jan; 7(1):110-20. PubMed ID: 18202014
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer.
Xiao Y; Jin L; Deng C; Guan Y; Kalogera E; Ray U; Thirusangu P; Staub J; Sarkar Bhattacharya S; Xu H; Fang X; Shridhar V
Oncogene; 2021 Feb; 40(8):1409-1424. PubMed ID: 33420377
[TBL] [Abstract][Full Text] [Related]
4. PFKFB3-mediated glycolysis is involved in reactive astrocyte proliferation after oxygen-glucose deprivation/reperfusion and is regulated by Cdh1.
Lv Y; Zhang B; Zhai C; Qiu J; Zhang Y; Yao W; Zhang C
Neurochem Int; 2015 Dec; 91():26-33. PubMed ID: 26498254
[TBL] [Abstract][Full Text] [Related]
5. AICAR enhances the cytotoxicity of PFKFB3 inhibitor in an AMPK signaling-independent manner in colorectal cancer cells.
Yan S; Yuan D; Li Q; Li S; Zhang F
Med Oncol; 2021 Nov; 39(1):10. PubMed ID: 34761330
[TBL] [Abstract][Full Text] [Related]
6. PFKFB3 Inhibition Impairs Erlotinib-Induced Autophagy in NSCLCs.
Lypova N; Dougherty SM; Lanceta L; Chesney J; Imbert-Fernandez Y
Cells; 2021 Jul; 10(7):. PubMed ID: 34359849
[TBL] [Abstract][Full Text] [Related]
7. COPS3 inhibition promotes cell proliferation blockage and anoikis via regulating PFKFB3 in osteosarcoma cancer cells.
Zhang F; Li Q; Zhang Y; Li N; Rao M; Li S; Ai Z; Yan S; Tian Z
Eur J Pharmacol; 2023 Jul; 951():175799. PubMed ID: 37201626
[TBL] [Abstract][Full Text] [Related]
8. [PFKFB3 regulates 11'-deoxyverticillin A (C42)-induced autophagy and apoptosis in HeLa cells].
Qin P; Chen T; Lu Q; Hu F; Yang H
Wei Sheng Wu Xue Bao; 2015 Nov; 55(11):1392-401. PubMed ID: 26915220
[TBL] [Abstract][Full Text] [Related]
9. PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis.
Peng F; Li Q; Sun JY; Luo Y; Chen M; Bao Y
Int J Oncol; 2018 Mar; 52(3):945-954. PubMed ID: 29393396
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
[TBL] [Abstract][Full Text] [Related]
11. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
[TBL] [Abstract][Full Text] [Related]
13. PFK15, a PFKFB3 antagonist, inhibits autophagy and proliferation in rhabdomyosarcoma cells.
Wang C; Qu J; Yan S; Gao Q; Hao S; Zhou D
Int J Mol Med; 2018 Jul; 42(1):359-367. PubMed ID: 29620138
[TBL] [Abstract][Full Text] [Related]
14. Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3).
Imbert-Fernandez Y; Clem BF; O'Neal J; Kerr DA; Spaulding R; Lanceta L; Clem AL; Telang S; Chesney J
J Biol Chem; 2014 Mar; 289(13):9440-8. PubMed ID: 24515104
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation.
Telang S; Clem BF; Klarer AC; Clem AL; Trent JO; Bucala R; Chesney J
J Transl Med; 2012 May; 10():95. PubMed ID: 22591674
[TBL] [Abstract][Full Text] [Related]
16. PFKFB3 promotes endotoxemia-induced myocardial dysfunction through inflammatory signaling and apoptotic induction.
Tian W; Guo HS; Li CY; Cao W; Wang XY; Mo D; Hao XW; Feng YD; Sun Y; Lei F; Zhang HN; Zhao MG; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 368():26-36. PubMed ID: 30776389
[TBL] [Abstract][Full Text] [Related]
17. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-137 chemosensitizes colon cancer cells to the chemotherapeutic drug oxaliplatin (OXA) by targeting YBX1.
Guo Y; Pang Y; Gao X; Zhao M; Zhang X; Zhang H; Xuan B; Wang Y
Cancer Biomark; 2017; 18(1):1-9. PubMed ID: 28035913
[TBL] [Abstract][Full Text] [Related]
19. Akt inhibition attenuates rasfonin-induced autophagy and apoptosis through the glycolytic pathway in renal cancer cells.
Lu Q; Yan S; Sun H; Wang W; Li Y; Yang X; Jiang X; Che Y; Xi Z
Cell Death Dis; 2015 Dec; 6(12):e2005. PubMed ID: 26633711
[TBL] [Abstract][Full Text] [Related]
20. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3 spatially mediates autophagy through the AMPK signaling pathway.
Yan S; Wei X; Xu S; Sun H; Wang W; Liu L; Jiang X; Zhang Y; Che Y
Oncotarget; 2017 Oct; 8(46):80909-80922. PubMed ID: 29113354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
